- Home
- TANH vs RDHL Comparison
TANH vs RDHL Comparison
Compare TANH & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TANH
- RDHL
- Stock Information
- Founded
- TANH 2001
- RDHL 2009
- Country
- TANH China
- RDHL Israel
- Employees
- TANH N/A
- RDHL N/A
- Industry
- TANH
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- TANH
- RDHL Health Care
- Exchange
- TANH Nasdaq
- RDHL Nasdaq
- Market Cap
- TANH 3.5M
- RDHL 3.8M
- IPO Year
- TANH 2015
- RDHL N/A
- Fundamental
- Price
- TANH $2.11
- RDHL $1.85
- Analyst Decision
- TANH
- RDHL
- Analyst Count
- TANH 0
- RDHL 0
- Target Price
- TANH N/A
- RDHL N/A
- AVG Volume (30 Days)
- TANH 474.6K
- RDHL 250.7K
- Earning Date
- TANH 06-10-2025
- RDHL 04-10-2025
- Dividend Yield
- TANH N/A
- RDHL N/A
- EPS Growth
- TANH N/A
- RDHL N/A
- EPS
- TANH 38.81
- RDHL N/A
- Revenue
- TANH $49,103,298.00
- RDHL $8,042,999.00
- Revenue This Year
- TANH N/A
- RDHL $381.91
- Revenue Next Year
- TANH N/A
- RDHL N/A
- P/E Ratio
- TANH $0.06
- RDHL N/A
- Revenue Growth
- TANH 6.14
- RDHL 23.17
- 52 Week Low
- TANH $1.45
- RDHL $1.80
- 52 Week High
- TANH $63.60
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- TANH 49.29
- RDHL 35.63
- Support Level
- TANH $1.93
- RDHL $1.76
- Resistance Level
- TANH $2.30
- RDHL $2.05
- Average True Range (ATR)
- TANH 0.31
- RDHL 0.15
- MACD
- TANH 0.03
- RDHL 0.01
- Stochastic Oscillator
- TANH 9.77
- RDHL 23.73
About TANH Tantech Holdings Ltd.
Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company through its subsidiaries is engaged in the production and distribution of household products along with a trading business which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments; the Consumer Product segment, and the Electric Vehicle (EV) segment.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.